Skip to main content

Houston Delegation Travels to Brazil to Strengthen Global Ties

Published May 03, 2023 by Taylor Tatum

Brazil trade mission 2023
Board meeting during Brazil Trade Mission 2023

Investment opportunities in energy transition, manufacturing, technology, and the port were the focus of a recent trade and investment mission to Houston’s fourth-largest international trading partner, Brazil. The Greater Houston Partnership, Mayor Sylvester Turner, and the Brazil-Texas Chamber of Commerce led the week-long mission to promote the Houston region as a top global destination for trade and investment. 

Houston-Brazil trade has grown steadily since 2016, despite a dip in 2020. In 2022, trade increased by 20% to $20.1 billion from $16.8 billion in 2021. More than 8,135 people living in metro Houston were born in Brazil. 

“Brazil is one of Houston’s most important international partners, with a record-breaking year for trade in 2022,” said John Cypher, Vice President of International Investment and Trade at the Partnership. “A number of Brazilian companies already have significant investment in Houston including Oxiteno, Petrobas and Novonor.”

Seven Brazilian firms operate 12 subsidiaries in the Houston area and 44 Houston firms operate 119 subsidiary locations in Brazil including Airswift, McDermott and SLB.  

The delegation also included Houston business leaders from the Houston Airport System, Port Houston, United Airlines, Radix, EPAM Systems, MCA Engineering LLC and Squire Patton Boggs LLP. High-level meetings included: 

  • Eduardo Paes, Mayor of Rio de Janeiro 

  • Claudio Castro, Governor of Rio de Janeiro

  • Marilia Marton, Secretary of Culture and Creative Economy of the State of Sao Paulo

  • Petrobras, a state-owned Brazilian multinational corporation in the petroleum industry. 

  • BRASKEM

  • Radix

  • Novonor

  • Raizen 

Additionally, members of the Partnership’s International Investment & Trade team promoted Houston’s emerging digital technology and innovation ecosystem during meetings with Invest Sao Paulo, Brazilian National Agency of Petroleum, Natural Gas and Biofuels (ANP), Federation of Industries of the State of São Paulo (FIESP), and AMCHAM. 

Houston’s energy transition efforts and the importance of building stronger ties with our South American allies to bolster these efforts took center stage in meetings with Porto do Açu, the Industry Federation for the State of Rio de Janeiro (Firjan), and the Brazilian Institute of Oil & Gas. Representatives including IBP President and CEO Roberto Ardenghy, Radix CEO João Carlos Chachamovitz, and Sotreq S.A. CEO Marcelo Orberg discussed accelerating low-carbon industrialization and sustainable development.

According to Cypher, the ports in Brazil are looking to Houston for how to best support the energy transition. The ports are building numerous terminals that will contribute to energy transition efforts, including hydrogen, carbon capture and sequestration.

The delegation also met with Mauricio Tomalsquim, Director of Energy Transition and Sustainability from Petrobras, who shared recent developments in Brazil’s energy transition space. Following productive meetings in Brazil, the Partnership and the Houston Energy Transition Initiative team hosted an in-bound delegation of Petrobras' representatives during the Offshore Technology Conference in Houston to discuss challenges and opportunities in CCUS and hydrogen for both regions as part of continued efforts to facilitate collaboration and business development.

Learn more about international business in Houston.

Related News

Life Sciences

MD Anderson, Rice University Launch New Collaborative to Advance Cancer Research

7/2/24
A new collaboration between The University of Texas MD Anderson Cancer Center and Rice University promises to drive industry growth and advance life-saving technologies through the newly established Cancer Bioengineering Collaborative. The initiative will help foster collaboration between the two institutions on fundamental and translational cancer research, develop new technologies for cancer detection and therapy, and secure external funding in support of further research and training. Rice researcher and Cancer Prevention and Research Institute of Texas (CPRIT) scholar Gang Bao and MD Anderson’s Dr. Jeffrey Molldrem will lead the hub.  “From fundamental discoveries in cancer science, tumor immunology and patient care to innovative engineering advances in drug delivery systems, nanostructures and synthetic biology, there is great potential for enabling cross-disciplinary collaboration to develop new technologies and approaches for detecting, monitoring and treating cancer,” Molldrem, chair of Hematopoietic Biology & Malignancy at MD Anderson, said in a release. “Our goal is to bridge the gap between bioengineering and cancer research to create transformative solutions that significantly improve patient outcomes.” The collaborative will also host monthly seminars focused on cancer bioengineering, annual retreats to highlight research and international leaders in cancer and bioengineering. Five research areas will be at the core of the hub’s work: Cell therapies: Developing more effective cell-based immunotherapies, including chimeric antigen receptor- and T cell receptor-based approaches. Nanotechnologies: Using nanoparticles for targeted cancer detection and therapy. Cancer vaccines: Incorporating advanced biomaterials, synthetic biology and nanoparticle delivery systems to develop therapeutic cancer vaccines. Artificial intelligence: Leveraging advanced computing tools for high-precision analysis of samples to identify new targets and inform therapeutic design. Molecular imaging: Deploying advanced molecular imaging techniques to enhance diagnostic and therapeutic tools. A seed grant program will also be established to fund research projects in the early stages of development. The partnership between Rice and MD Anderson is a testament to how the greater Houston region is committed to advancing the life sciences and biotech industry. The region has seen major new life science developments come online recently, including Levit Green, TMC Helix Park and The Alexandria Center for Advanced Technologies in The Woodlands.   
Read More
Life Sciences

The Woodlands Innovation District Aims to Attract Life Sciences Companies

6/28/24
A new district in The Woodlands hopes to expand on the area’s resurgence in life sciences developments.    Post pandemic, life sciences companies have been establishing facilities in The Woodlands, particularly along Research Forest Drive. And now, Developers Howard Hughes and Vitrian are building upon that growth by adding an additional 86.3 acres for future development, aiming to attract more biomanufacturing companies to the area. The duo has dubbed the area The Woodlands Innovation District.  “This joint venture further diversifies the innovative industries that are represented in The Woodlands with the advancement of life science,” said Jim Carman, President of the Houston Region for The Howard Hughes Corporation in a statement. “The Woodlands continues to attract companies from a variety of industries seeking a highly-skilled talent pool, business-friendly environment, and high quality of life for their employees.”  The district joins the area’s cluster of existing life sciences companies, such as Millipore Sigma and VGXI. Cellipont Bioservices, a San Diego-based cell therapy contract development and manufacturing organization, recently opened a 76,000-square-foot facility in the area. The facility is dedicated to cell therapies and serves as the company's new headquarters.  Cellipont’s move to the greater Houston region, announced in 2022, kickstarted a surge in life sciences activity in The Woodlands. Bionova Scientific, another California-based biotech company, recently announced plans to expand into the area, with a 100,000-square-foot manufacturing and research facility. The company, which produces materials used by cancer-fighting cell therapy companies, is expected to begin operations at the new location in 2025.  Nearby, Nurix Therapeutics, a clinical-stage biopharmaceutical company based in San Francisco, has relocated to the Alexandria Center for Advanced Technologies. This 12-acre life sciences campus, formerly the Lexicon Pharmaceuticals site, was inaugurated last year with support from Lexicon’s Founder and CEO and now Nurix's Chief Executive Officer, Arthur Sands. Backed by California-based real estate firm Alexandria Real Estate Equities, the campus is still being built out, with the goal of becoming a smaller version of The Texas Medical Center.   These recent developments have established The Woodlands as a leader in life sciences in the region. According to CBRE’s 2023 U.S. Life Sciences Outlook, The Woodlands accounted for 60% of the Houston region’s life sciences lease transactions in 2022.  The Woodlands Innovation District will encompass five sites, each providing tenant facilities ranging from 40,000 to over 200,000 square feet. These sites will offer build-to-suit shell spaces, anticipated to be move-in ready by Spring 2025.  Learn more about Houston’s life sciences and biotechnology industries. 
Read More

Related Events

Economy

Houston Region Economic Outlook

Featuring economists and industry leaders, the Houston Region Economic Outlook takes a close look at the core industries driving job growth and economic indicators measuring the strength of our economy.…

Learn More
Learn More
Executive Partners